上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性，接下來我們將會繼續深入探討問題。1347Please respect copyright.ＰＥＮＡＮＡQYfpmie8Zi
1347Please respect copyright.ＰＥＮＡＮＡ1wwCpvaEEt
上集：https://www.penana.com/article/4711251347Please respect copyright.ＰＥＮＡＮＡowbNbH59Mf
1347Please respect copyright.ＰＥＮＡＮＡlU5D90JPYk
1347Please respect copyright.ＰＥＮＡＮＡ78dlNiXN4N
1347Please respect copyright.ＰＥＮＡＮＡ2oEoKs19Mk
（圖1）雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力，但另一個重要的問題是，如何確保有足夠的T cell殺滅癌細胞呢?1347Please respect copyright.ＰＥＮＡＮＡryLxCWMMuj
1347Please respect copyright.ＰＥＮＡＮＡoRTu7SbIKo
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物，但免疫系統細胞數量不足的話，依然是不會達到重大效果的。1347Please respect copyright.ＰＥＮＡＮＡhTdqOEfXMv
1347Please respect copyright.ＰＥＮＡＮＡYdEzUJ9KTt
換句話說，我們需要一道能夠提升針對癌細胞的T cell數量手段。1347Please respect copyright.ＰＥＮＡＮＡG6AOXKVORv
1347Please respect copyright.ＰＥＮＡＮＡ7xdK4NJnEY
1347Please respect copyright.ＰＥＮＡＮＡOzWoIvDky0
1347Please respect copyright.ＰＥＮＡＮＡtukONjqUIw
（圖2）T cell的產生數量，接近可以說是由Antigen Presenting Cells(APC)來決定;1347Please respect copyright.ＰＥＮＡＮＡ5GshWZv2yH
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1347Please respect copyright.ＰＥＮＡＮＡaCbWOwpZ4f
1347Please respect copyright.ＰＥＮＡＮＡgh0k9ilOOA
忘記甚麼是Neoantigen的話，可重溫上一集。1347Please respect copyright.ＰＥＮＡＮＡlWZIhrGLqM
1347Please respect copyright.ＰＥＮＡＮＡghpUsmPZ2f
當APC展示癌細胞的Neoantigen予T cell的receptor後，另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1347Please respect copyright.ＰＥＮＡＮＡB7jKHqJ9Z7
1347Please respect copyright.ＰＥＮＡＮＡer4goZn99s
只要兩者條件達成的話，負責對付對應癌細胞的T cell數量及效力便會大增。1347Please respect copyright.ＰＥＮＡＮＡm0QorwDQyu
1347Please respect copyright.ＰＥＮＡＮＡoqabQWqAaG
1347Please respect copyright.ＰＥＮＡＮＡWYGviE9TVS
1347Please respect copyright.ＰＥＮＡＮＡV35E6cTD8P
（圖3）然而，當T cell數量產生至一定程度的時候，T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置，與B7合併。1347Please respect copyright.ＰＥＮＡＮＡ5ku8yNIdmr
1347Please respect copyright.ＰＥＮＡＮＡQGwKC6czVj
而當CTLA4與B7合併後，T cell所產生的數量及威力就會大減。1347Please respect copyright.ＰＥＮＡＮＡr83jxc5BGa
1347Please respect copyright.ＰＥＮＡＮＡmll8IRd7wG
這個CTLA4產生的機制是與生俱來的，目的就是為了避免產生過量的T cell，以免身體會產生不良反應。1347Please respect copyright.ＰＥＮＡＮＡk2aO7j1Pea
1347Please respect copyright.ＰＥＮＡＮＡpEizOKc658
1347Please respect copyright.ＰＥＮＡＮＡpm2RVhKZLx
（圖4）只不過的是，現時癌細胞大敵當前，燃眉之急就是要調動大量的T cell前往討伐癌細胞。1347Please respect copyright.ＰＥＮＡＮＡ9dbsS4HlkG
1347Please respect copyright.ＰＥＮＡＮＡcrKGey3pCb
為此，我們重施應對PD1/PDL1故技，利用抗體阻擋CTLA4，確保CD28及B7持續合併，不斷產生效力高強的T cell。1347Please respect copyright.ＰＥＮＡＮＡ38CdZduju8
1347Please respect copyright.ＰＥＮＡＮＡh029SsXWyj
1347Please respect copyright.ＰＥＮＡＮＡGOT22ZzScw
（圖5）簡略的總結來說，為了確保有足夠的T cell消滅癌細胞，我們不惜採用阻擋CTLA4的抗體，號令身體持續產生效力高強的T cell。1347Please respect copyright.ＰＥＮＡＮＡjLLDIyQZRB
而另一邊廂，我們亦同時利用阻擋PD1/PDL1的抗體，確保T cell能夠順利把癌細胞辨認成為外來物，將其制裁。1347Please respect copyright.ＰＥＮＡＮＡiiJpGBy6vy
1347Please respect copyright.ＰＥＮＡＮＡijHxcZsvAK
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法，將能大大提升免疫治療的效率。1347Please respect copyright.ＰＥＮＡＮＡppXpXO2XSx
1347Please respect copyright.ＰＥＮＡＮＡNgiauWX02R
但是，並不是所有病人也能依靠這方法而得益，原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1347Please respect copyright.ＰＥＮＡＮＡorRNeWJhJ9
1347Please respect copyright.ＰＥＮＡＮＡjILa0Yz3tU
這一方面，我們將會在下一篇免疫治療的最終章再作探討。1347Please respect copyright.ＰＥＮＡＮＡ31PkFsPiig
1347Please respect copyright.ＰＥＮＡＮＡ22RQ9ekE3g
1347Please respect copyright.ＰＥＮＡＮＡQh9rnNX8du
如果想我快啲出文的話，請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark，這對我非常之重要。1347Please respect copyright.ＰＥＮＡＮＡE4f6zuauZy
1347Please respect copyright.ＰＥＮＡＮＡo3B5XIEfnx
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1347Please respect copyright.ＰＥＮＡＮＡGhEWS1DlaV
1347Please respect copyright.ＰＥＮＡＮＡLjiQSlkJ90
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」，以課金的方式推動我繼續搜羅資料寫文，多謝。1347Please respect copyright.ＰＥＮＡＮＡVdFyt0mk69
1347Please respect copyright.ＰＥＮＡＮＡ6LVCbr2Bj2
Link:1347Please respect copyright.ＰＥＮＡＮＡqRPYfT2pwn
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1347Please respect copyright.ＰＥＮＡＮＡ5qR5Rdn3w2
1347Please respect copyright.ＰＥＮＡＮＡx4t9goJFMj
1347Please respect copyright.ＰＥＮＡＮＡ9dHLKdFYDG
有興趣接收科普資訊的話，歡迎follow IG: potatopigtongue。1347Please respect copyright.ＰＥＮＡＮＡiG5KnDHhCu
Penana
search
登入arrow_drop_down
註冊arrow_drop_down
